The subcutaneous dose had comparable efficacy to intravenous dosing while enhancing patient convenience in non–small cell lung cancer, explains Nicolas Girard, MD, PhD.
Nicolas Girard, MD, PhD
Advertisement
Articles by Nicolas Girard, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
2
FDA Approves Second Generic Mifepristone Pill for Abortion
3
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
4
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
5
